NEW YORK, Oct. 13, 2016 -- Wix.com Ltd. (Nasdaq:WIX), a leading global software platform for small businesses to operate online, today announced that it will report its results for the third quarter ended September 30, 2016 before the market open on Thursday, November 10, 2016. Management will host a conference call and webcast that morning at 8:30 a.m. ET to answer questions about the Company's financial results. Prior to the conference call and webcast, Wix will issue a press release reporting these results along with a shareholder update and additional materials at https://investors.wix.com/.
| What: | Wix.com Third Quarter 2016 Results Conference Call | |
| When: | Thursday, November 10, 2016 | |
| Time: | 8:30 a.m. ET | |
| Live Call: | US/Canada Toll-Free: 866-393-4306 | |
| International: 734-385-2616 | ||
| Israel Toll-Free: 809-315-362 | ||
| Replay: | US/Canada Toll-Free: 855-859-2056 | |
| International: 404-537-3406 | ||
| Conference ID: 92202490 | ||
| (Available approximately two hours after the completion of the live call until 11:59 p.m. ET on November 15, 2016) | ||
| Webcast: | https://investors.wix.com/ | |
About Wix.com Ltd.
Wix.com is a leading global software platform for small businesses to operate online with over 93 million registered users worldwide. Wix was founded on the belief that the Internet should be accessible to everyone to develop, create and contribute. Through free and premium subscriptions, Wix empowers millions of businesses, organizations, professionals and individuals to take their businesses, brands and workflow online. Wix ADI, the Wix Editor and a highly curated App Market enable users to build and manage a fully integrated and dynamic digital presence. Wix's headquarters are in Tel Aviv with offices in Be'er Sheva, San Francisco, New York, Miami, Berlin, Vilnius and Dnepropetrovsk.
Investor Relations: Ryan Gee [email protected] 415-223-2610 Media Relations: Vivian Hernandez [email protected] 415-517-6539


AstraZeneca’s LATIFY Phase III Trial of Ceralasertib Misses Primary Endpoint in Lung Cancer Study
Maersk Vessel Successfully Transits Red Sea After Nearly Two Years Amid Ongoing Security Concerns
JPMorgan’s Top Large-Cap Pharma Stocks to Watch in 2026
Harris Associates Open to Revised Paramount Skydance Bid for Warner Bros Discovery
Uber and Baidu Partner to Test Robotaxis in the UK, Marking a New Milestone for Autonomous Ride-Hailing
7-Eleven CEO Joe DePinto to Retire After Two Decades at the Helm
TikTok U.S. Deal Advances as ByteDance Signs Binding Joint Venture Agreement
Trump Administration Reviews Nvidia H200 Chip Sales to China, Marking Major Shift in U.S. AI Export Policy
Volaris and Viva Agree to Merge, Creating Mexico’s Largest Low-Cost Airline Group
Italy Fines Apple €98.6 Million Over App Store Dominance
Niigata Set to Approve Restart of Japan’s Largest Nuclear Power Plant in Major Energy Shift
Moore Threads Unveils New GPUs, Fuels Optimism Around China’s AI Chip Ambitions
Google and Apple Warn U.S. Visa Holders to Avoid International Travel Amid Lengthy Embassy Delays
FDA Fast-Tracks Approval of Altria’s on! PLUS Nicotine Pouches Under New Pilot Program
Delta Air Lines President Glen Hauenstein to Retire, Leaving Legacy of Premium Strategy
Toyota to Sell U.S.-Made Camry, Highlander, and Tundra in Japan From 2026 to Ease Trade Tensions 



